Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

Shell legt Grundstein f r weltgr sstes Werk

Article Abstract:

German Hamburg-based Shell Solar Deutschland GmbH is building in Gelsenkirchen the world's largest factory for solar cell production. The Royal Dutch/Shell group expects renewable energies to meet 5-10% of the world's energy demand in 2010. At present, solar energy accounts only for 0.004% of Germany's electricity generation. With the new plant, Shell is to contribute to the development of solar energy technology to a fully competitive level. Innovative production methods, such as thin-film technology, are to cut production costs by half. Later on, 13mn solar cells with a capacity of 24 MV are to be produced annually in Gelsenkirchen. The first production line is to be put into operation in the summer of 1999. A part of the factory's production is to be used for modules which Pilkington Solar International is to produce in a factory near by. Pilkington, which holds a 20% stake in Shell Solar, is to invest DM 30mn in the module factory which is also to have an information centre for solar energy.

Comment:

Is building in Gelsenkirchen the worlds' largest factory for solar cell production

Publisher: Vogt-Schild AG
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 1998
Semiconductor and Related Device Manufacturing, Solar Cells, Photoelectric cells, Article, Shell Solar Deutschland GmbH

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


GERMANY: DEGUSSA-HULS EXPANDS CAPACITY

Article Abstract:

Degussa-Huls has increased production capacity for dimethylterephthalate (DMT) at its factories in Lulsdorf and Steyerberg to 240,000 tpy each. Thus the company's overall capacity for the agent that is used in the production of chemical fibres rises by 50,000 tpy to 480,000 tpy. In Lulsdorf, Degussa-Huls has brought on stream a 10,000-tpy production facility for carbonic acid derivatives, of which it is the leading supplier worldwide. The investment amounted to DM 145mn.

Publisher: Vogt-Schild AG
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 1999
Chemicals & Allied Products, Chemical Manufacturing, Chemicals, Degussa-Huls

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


GERMANY: COMPOSTING PLANT FOR HANOVER

Article Abstract:

By the Expo 2000 world exposition, Lurgi Entsorgung GmbH is to build new waste treatment plants for Hanover, Germany. A composting plant with an annual capacity of 40,000 t is to have an integrated sewage treatment unit. Also a plant for mechanical handling of non-organic waste is to be built. Investments are to total DM 40mn.

Publisher: Vogt-Schild AG
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 1998
Refuse Systems Equip, Other Commercial and Service Industry Machinery Manufacturing, Waste disposal equipment, Waste treatment equipment, Lurgi Entsorgung GmbH

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Germany
Similar abstracts:
  • Abstracts: Germany: Rhodia to step up latex production. GERMANY: BASF UPS PAPER CHEMICALS CAPACITY
  • Abstracts: SWITZERLAND: CIBA INVESTING IN HALS. GERMANY: JOINT VENTURE FOR CONSTAB, RESINEX
  • Abstracts: GERMANY: CHILDREN'S VACCINE MARKET. GERMANY: SIMULATION SOFTWARE FOR AUTOMOTIVE R&D. GERMANY: NEW SGL UNIT FOR CORROSION PROTECTION
  • Abstracts: Markante Verbesserung des Ertrags SWITZERLAND: CAPSTAR BY NOVARTIS ANIMAL HEALTH. SWITZERLAND: LOGISTICS OUTSOURCING BY NOVARTIS
  • Abstracts: BASF kauft Butandiol-Technologie von Kvaerner GERMANY: BAYER RAISES CRELAN CAPACITY. GERMANY: NEW UNIVERSITY CHAIR WITH HENKEL
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2026 Advameg, Inc.